Logo image of CLNE

CLEAN ENERGY FUELS CORP (CLNE) Stock Fundamental Analysis

NASDAQ:CLNE - Nasdaq - US1844991018 - Common Stock - Currency: USD

2.02  -0.69 (-25.46%)

Premarket: 1.96 -0.06 (-2.97%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CLNE. CLNE was compared to 210 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of CLNE is average, but there are quite some concerns on its profitability. While showing a medium growth rate, CLNE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CLNE was profitable.
In the past year CLNE had a positive cash flow from operations.
In the past 5 years CLNE always reported negative net income.
CLNE had a positive operating cash flow in 4 of the past 5 years.
CLNE Yearly Net Income VS EBIT VS OCF VS FCFCLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

CLNE has a worse Return On Assets (-5.75%) than 85.22% of its industry peers.
Looking at the Return On Equity, with a value of -9.88%, CLNE is doing worse than 80.30% of the companies in the same industry.
Industry RankSector Rank
ROA -5.75%
ROE -9.88%
ROIC N/A
ROA(3y)-7.68%
ROA(5y)-4.36%
ROE(3y)-11.43%
ROE(5y)-6.48%
ROIC(3y)N/A
ROIC(5y)N/A
CLNE Yearly ROA, ROE, ROICCLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20 -30 -40

1.3 Margins

The Gross Margin of CLNE (29.73%) is worse than 60.59% of its industry peers.
In the last couple of years the Gross Margin of CLNE has declined.
CLNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.26%
GM growth 5Y-13.03%
CLNE Yearly Profit, Operating, Gross MarginsCLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20

More info and screens

4

2. Health

2.1 Basic Checks

CLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
CLNE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLNE Yearly Shares OutstandingCLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
CLNE Yearly Total Debt VS Total AssetsCLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of -0.04, we must say that CLNE is in the distress zone and has some risk of bankruptcy.
CLNE has a worse Altman-Z score (-0.04) than 73.40% of its industry peers.
CLNE has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
CLNE has a Debt to Equity ratio of 0.37. This is comparable to the rest of the industry: CLNE outperforms 51.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z -0.04
ROIC/WACCN/A
WACC8.91%
CLNE Yearly LT Debt VS Equity VS FCFCLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

CLNE has a Current Ratio of 3.06. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
CLNE has a Current ratio of 3.06. This is amongst the best in the industry. CLNE outperforms 81.28% of its industry peers.
CLNE has a Quick Ratio of 2.74. This indicates that CLNE is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.74, CLNE belongs to the top of the industry, outperforming 82.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.06
Quick Ratio 2.74
CLNE Yearly Current Assets VS Current LiabilitesCLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 166.67% over the past year.
Measured over the past years, CLNE shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.00% on average per year.
EPS 1Y (TTM)166.67%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%100%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.31%

3.2 Future

Based on estimates for the next years, CLNE will show a very strong growth in Earnings Per Share. The EPS will grow by 65.71% on average per year.
Based on estimates for the next years, CLNE will show a very strong growth in Revenue. The Revenue will grow by 22.39% on average per year.
EPS Next Y-307.65%
EPS Next 2Y-11.09%
EPS Next 3Y117.77%
EPS Next 5Y65.71%
Revenue Next Year6.24%
Revenue Next 2Y12.75%
Revenue Next 3Y31.55%
Revenue Next 5Y22.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
CLNE Yearly Revenue VS EstimatesCLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
CLNE Yearly EPS VS EstimatesCLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.5 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

CLNE is valuated quite expensively with a Price/Earnings ratio of 50.50.
Based on the Price/Earnings ratio, CLNE is valued a bit more expensive than the industry average as 71.43% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 29.43, CLNE is valued quite expensively.
CLNE is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 50.5
Fwd PE N/A
CLNE Price Earnings VS Forward Price EarningsCLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLNE is valued a bit more expensive than 75.37% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.88
CLNE Per share dataCLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as CLNE's earnings are expected to grow with 117.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.09%
EPS Next 3Y117.77%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLNE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEAN ENERGY FUELS CORP

NASDAQ:CLNE (2/25/2025, 8:25:48 PM)

Premarket: 1.96 -0.06 (-2.97%)

2.02

-0.69 (-25.46%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-24 2025-02-24/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners51.01%
Inst Owner Change-95.77%
Ins Owners0.86%
Ins Owner Change0%
Market Cap451.39M
Analysts84
Price Target7 (246.53%)
Short Float %5.82%
Short Ratio4.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)157.18%
Min EPS beat(2)128.59%
Max EPS beat(2)185.77%
EPS beat(4)4
Avg EPS beat(4)183.34%
Min EPS beat(4)77.37%
Max EPS beat(4)341.62%
EPS beat(8)7
Avg EPS beat(8)110.96%
EPS beat(12)9
Avg EPS beat(12)68.52%
EPS beat(16)10
Avg EPS beat(16)-400.75%
Revenue beat(2)1
Avg Revenue beat(2)-3.87%
Min Revenue beat(2)-9.94%
Max Revenue beat(2)2.21%
Revenue beat(4)2
Avg Revenue beat(4)-1.58%
Min Revenue beat(4)-9.94%
Max Revenue beat(4)2.21%
Revenue beat(8)3
Avg Revenue beat(8)-0.84%
Revenue beat(12)4
Avg Revenue beat(12)-2.14%
Revenue beat(16)7
Avg Revenue beat(16)-7.57%
PT rev (1m)-1.59%
PT rev (3m)-5.04%
EPS NQ rev (1m)-2.06%
EPS NQ rev (3m)-2.06%
EPS NY rev (1m)46.15%
EPS NY rev (3m)49.98%
Revenue NQ rev (1m)1.11%
Revenue NQ rev (3m)2.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE 50.5
Fwd PE N/A
P/S 1.09
P/FCF N/A
P/OCF 5.27
P/B 0.62
P/tB 0.69
EV/EBITDA 23.88
EPS(TTM)0.04
EY1.98%
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.38
OCFY18.99%
SpS1.85
BVpS3.24
TBVpS2.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.75%
ROE -9.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.73%
FCFM N/A
ROA(3y)-7.68%
ROA(5y)-4.36%
ROE(3y)-11.43%
ROE(5y)-6.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.26%
GM growth 5Y-13.03%
F-Score5
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 18.29
Cap/Depr 218.88%
Cap/Sales 23.57%
Interest Coverage N/A
Cash Conversion 590.7%
Profit Quality N/A
Current Ratio 3.06
Quick Ratio 2.74
Altman-Z -0.04
F-Score5
WACC8.91%
ROIC/WACCN/A
Cap/Depr(3y)142.46%
Cap/Depr(5y)101.96%
Cap/Sales(3y)17.52%
Cap/Sales(5y)13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)166.67%
EPS 3Y58.74%
EPS 5Y-21%
EPS Q2Q%100%
EPS Next Y-307.65%
EPS Next 2Y-11.09%
EPS Next 3Y117.77%
EPS Next 5Y65.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.31%
Revenue Next Year6.24%
Revenue Next 2Y12.75%
Revenue Next 3Y31.55%
Revenue Next 5Y22.39%
EBIT growth 1Y62.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year204.7%
EBIT Next 3Y53.44%
EBIT Next 5Y42.77%
FCF growth 1Y-362.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y113.26%
OCF growth 3Y-10.49%
OCF growth 5Y2.88%